RACHEL DAVIDIANS: Open Payments
NPI 1811582539 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 8 payments from 6 companies in 2025. Trend: 2023 $506 · 2024 $346 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 2 | $197 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Astellas Pharma US Inc | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Eisai Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: ELZONRIS, Vanflyta, Vyloy, JAKAFI, Lenvima, DANZITEN.
Industry payments across CA — which companies pay providers there.
